Rasmus Syberg Rasmussen

Rasmus Syberg Rasmussen serves as a Research Fellow in the Department of Biomedical Sciences at the University of Copenhagen's Faculty of Health and Medical Sciences. His research is conducted within the Molecular and Translational Pharmacology group, where he focuses on the intersection of pharmacological mechanisms and physiological responses with clinical applications.

Dr. Rasmussen's work spans multiple interconnected domains of biomedical science. His primary research interests include receptor pharmacology, particularly examining glucose-dependent insulinotropic polypeptide (GIP) receptors across species; metabolic regulation and blood flow dynamics; and exercise physiology as it relates to cardiac and pulmonary function. He employs both molecular and translational approaches to bridge basic science discoveries with potential clinical applications, particularly in diabetes research and post-disease recovery. His publications demonstrate expertise in comparative receptor biology, metabolic hormone function, and physiological adaptations to interventions.

Analysis of his recent publications reveals a cohesive research trajectory focused on incretin biology and its physiological implications. His work on GIP receptor mechanisms across species addresses fundamental challenges in drug development, while his investigations into postprandial blood flow regulation and cardiac recovery after COVID-19 demonstrate the translational potential of his research. The multidisciplinary nature of his work connects molecular pharmacology with whole-body physiology, creating a bridge between basic science and clinical applications in metabolic and cardiovascular health.

Rasmus Syberg Rasmussen is actively engaged in collaborative research within the Molecular and Translational Pharmacology group at the University of Copenhagen. His work benefits from the institution's strong emphasis on translational medicine, connecting laboratory findings with patient care and therapeutic development. His research network includes collaborations across pharmacology, endocrinology, cardiology, and sports medicine disciplines, reflecting the interdisciplinary nature of modern biomedical research.